Table 4. Multivariable exponential regression model for disease free survival.
estimate | sd | z | HR | 95% CI Lower | 95% CI Upper | p value | |
---|---|---|---|---|---|---|---|
(Intercept) | 6.011 | 0.54 | 11.134 | ||||
Age (each 5 years) | -0.048 | 0.038 | -1.278 | 1.05 | 0.974 | 1.131 | 0.201 |
Pleural Invasion (yes.vs.no) | -0.249 | 0.186 | -1.337 | 1.282 | 0.891 | 1.846 | 0.181 |
Tumor Size | |||||||
T1a (baseline group) | - | - | - | 1.0 | - | - | |
T1b | -0.224 | 0.205 | -1.093 | 1.251 | 0.837 | 1.869 | 0.274 |
T2a | -0.82 | 0.194 | -4.222 | 2.271 | 1.552 | 3.324 | <0.001 |
T2b | -0.599 | 0.285 | -2.103 | 1.821 | 1.042 | 3.184 | 0.035 |
T3 | -1.217 | 0.343 | -3.549 | 3.376 | 1.724 | 6.611 | <0.001 |
Performance status: some symptoms vs. normal | -0.061 | 0.155 | -0.395 | 1.063 | 0.785 | 1.441 | 0.692 |
Performance status: < 50% of time in bed vs. normal | -1.521 | 0.36 | -4.224 | 4.577 | 2.26 | 9.271 | <0.001 |
Gender F vs. M | 0.313 | 0.154 | 2.036 | 0.731 | 0.541 | 0.988 | 0.042 |
Histology: Squamous vs. Adenocarcinomas | 0.009 | 0.188 | 0.047 | 0.991 | 0.686 | 1.432 | 0.963 |
Histology: Other non-small cell vs. Adenocarcinomas | 0.092 | 0.203 | 0.452 | 0.912 | 0.612 | 1.359 | 0.651 |